Cyltezo Interactions
There are 558 drugs known to interact with Cyltezo (adalimumab), along with 8 disease interactions. Of the total drug interactions, 303 are major, 246 are moderate, and 9 are minor.
- View all 558 medications that may interact with Cyltezo
- View Cyltezo disease interactions (8)
Most frequently checked interactions
View interaction reports for Cyltezo (adalimumab) and the medicines listed below.
- acetaminophen
- azathioprine
- benzonatate
- biotin
- Claritin (loratadine)
- clindamycin
- colestipol
- Crestor (rosuvastatin)
- dicyclomine
- doxycycline
- Entyvio (vedolizumab)
- gabapentin
- hydroxyzine
- lisinopril
- loperamide
- magnesium oxide
- metronidazole
- octreotide
- omeprazole
- ondansetron
- Protonix (pantoprazole)
- Remicade (infliximab)
- Stelara (ustekinumab)
- sulfasalazine
- tramadol
- trazodone
- triamcinolone topical
- Viberzi (eluxadoline)
- Vitamin D3 (cholecalciferol)
- Xifaxan (rifaximin)
Cyltezo disease interactions
There are 8 disease interactions with Cyltezo (adalimumab) which include:
- infections
- malignancies
- neurologic reactions
- tuberculosis
- CHF
- COPD
- hematologic abnormalities
- hepatitis B
Report options
QR code containing a link to this page
More about Cyltezo (adalimumab)
- Cyltezo consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: TNF alfa inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
